ÂÜÀòÂÒÂ×

Alex McKeown is an accomplished professional in the field of ophthalmology research, currently serving as Senior Director at Apellis Pharmaceuticals since September 2020, where responsibilities include leading the development of candidate molecules through pre-clinical and proof of concept studies. In addition, Alex holds the position of Digital Programs Lead at the Boston Image Reading Center, focusing on adaptive optics and clinical trial optimization. Previous roles include grader for the Duke Image Reading Center, Medical Science Liaison at Novartis, and Clinical Market Development Manager at Heidelberg Engineering. Alex's academic background includes a Ph.D. in Vision Science/Physiological Optics from the University of Alabama at Birmingham, an M.B.A. from the UAB Collat School of Business, and a Bachelor's degree in Biochemistry and Molecular Biology from Boston University.